Supernus Pharmaceuticals
SUPN
#4333
Rank
NZ$3.37 B
Marketcap
$61.11
Share price
-0.83%
Change (1 day)
35.87%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$0.57 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.56 B-56.2%
2022-12-31NZ$1.28 B0.56%
2021-12-31NZ$1.27 B21.51%
2020-12-31NZ$1.05 B25.46%
2019-12-31NZ$0.83 B7.2%
2018-12-31NZ$0.78 B253.94%
2017-12-31NZ$0.22 B29.96%
2016-12-31NZ$0.17 B15.69%
2015-12-31NZ$0.14 B19.88%
2014-12-31NZ$0.12 B29.98%
2013-12-31NZ$94.34 M113.11%
2012-12-31NZ$44.27 M-21.98%
2011-12-31NZ$56.74 M-52.07%
2010-12-31NZ$0.11 B-0.08%
2009-12-31NZ$0.11 B-18.03%
2008-12-31NZ$0.14 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$1.74 B 204.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$104.56 B 18,164.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$130.46 B 22,689.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$58.56 B 10,130.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$184.47 B 32,124.31%๐Ÿ‡บ๐Ÿ‡ธ USA